Rovelizumab (anti-CD11a&CD18) (C09-1515-436)

Aladdin

Catalog No.: C09-1515-436
Manufacturer No.: Ab175649-100μg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $114.38

List Price: $127.09

Rovelizumab (anti-CD11a&:CD18) is a humanized monoclonal leukointegrin antibody. Rovelizumab (anti-CD11a&:CD18) is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab (anti-CD11a&:CD18) can be used for

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Rovelizumab (anti-CD11a&CD18) is a humanized monoclonal leukointegrin antibody. Rovelizumab (anti-CD11a&CD18) is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab (anti-CD11a&CD18) can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.Purity:≥95% (SDS-PAGE&SEC):Endotoxin Level:< 1.0EU/mg. Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot

UPC:: 51281817
Condition:: New
Availability:: 8-12 weeks
Weight:: 1.09 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: Ab175649-100μg
CAS:: 339086-79-2
Product Size:: 100μg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."